64 related articles for article (PubMed ID: 1944011)
1. LHRH-induced gonadotropin release before and after short-term therapy with cabergoline in hyperprolactinaemic patients.
Durante R; Giusti M; Carraro A; Porcella E
Minerva Endocrinol; 1991; 16(1):11-6. PubMed ID: 1944011
[TBL] [Abstract][Full Text] [Related]
2. Effect of subacute cabergoline treatment on prolactin, thyroid stimulating hormone and growth hormone response to simultaneous administration of thyrotrophin-releasing hormone and growth hormone-releasing hormone in hyperprolactinaemic women.
Giusti M; Lomeo A; Torre R; Sghedoni D; Mazzocchi G; Durante R; Giordano G
Clin Endocrinol (Oxf); 1989 Mar; 30(3):315-21. PubMed ID: 2574083
[TBL] [Abstract][Full Text] [Related]
3. Gender effects on cardiac valvular function in hyperprolactinaemic patients receiving cabergoline: a retrospective study.
Nachtigall LB; Valassi E; Lo J; McCarty D; Passeri J; Biller BM; Miller KK; Utz A; Grinspoon S; Lawson EA; Klibanski A
Clin Endocrinol (Oxf); 2010 Jan; 72(1):53-8. PubMed ID: 19508591
[TBL] [Abstract][Full Text] [Related]
4. Abnormal LH pulsatility in women with hyperprolactinaemic amenorrhoea normalizes after bromocriptine treatment: deconvolution-based assessment.
Sartorio A; Pizzocaro A; Liberati D; De Nicolao G; Veldhuis JD; Faglia G
Clin Endocrinol (Oxf); 2000 Jun; 52(6):703-12. PubMed ID: 10848874
[TBL] [Abstract][Full Text] [Related]
5. Catecholamines and pituitary-function. V. Effect of low-dose dopamine infusion on basal and gonadotropin-releasing hormone stimulated gonadotropin release in normal cycling women and patients with hyperprolactinemic amenorrhea.
Nicoletti I; Ambrosi F; Giammartino C; Fedeli L; Mannarelli C; Filipponi P
Horm Metab Res; 1986 Jul; 18(7):479-84. PubMed ID: 3091473
[TBL] [Abstract][Full Text] [Related]
6. Withdrawal of long-term cabergoline therapy for tumoral and nontumoral hyperprolactinemia.
Colao A; Di Sarno A; Cappabianca P; Di Somma C; Pivonello R; Lombardi G
N Engl J Med; 2003 Nov; 349(21):2023-33. PubMed ID: 14627787
[TBL] [Abstract][Full Text] [Related]
7. [Effect of methergoline on impulse secretion of gonadotropins in women with hyperprolactinemic ovarian insufficiency].
Potin VV; Svechnikova FA; Soboleva EL
Akush Ginekol (Mosk); 1989 Jul; (7):16-9. PubMed ID: 2802060
[TBL] [Abstract][Full Text] [Related]
8. Effect of metergoline on prolactin, follicle stimulating hormone, luteinizing hormone and thyroid stimulating hormone response to TRH and LHRH in normal men and women.
Sartani A; de Pasqua A; Cesati R; Farina L; Pontiroli AE
Horm Metab Res; 1984 Oct; 16(10):535-8. PubMed ID: 6437954
[TBL] [Abstract][Full Text] [Related]
9. Role of sex-hormone-binding globulin and free sex steroid hormones in hyperandrogenic anovulation.
Ohsawa M; Asai M; Masahashi T; Narita O; Tomoda Y; Matsui N
Nihon Sanka Fujinka Gakkai Zasshi; 1986 Nov; 38(11):2081-8. PubMed ID: 2947958
[TBL] [Abstract][Full Text] [Related]
10. Pituitary response to LHRH in hypothyroid women.
Drake TS; O'Brien WF; Tredway DR
Obstet Gynecol; 1980 Oct; 56(4):488-91. PubMed ID: 6775259
[TBL] [Abstract][Full Text] [Related]
11. Gonadotropic responsiveness to clomiphene, LRH, estradiol, and bromocriptine in galactorrheic women.
Forsbach G; Soria J; Canales ES; Guzman V; Cabezas A; Zárate A
Obstet Gynecol; 1977 Aug; 50(2):139-44. PubMed ID: 327363
[TBL] [Abstract][Full Text] [Related]
12. The role of serum PRL bioactivity evaluation in hyperprolactinaemic women with different menstrual disorders.
Kostrzak A; Warenik-Szymankiewicz A; Meczekalski B
Gynecol Endocrinol; 2009 Dec; 25(12):799-806. PubMed ID: 19905999
[TBL] [Abstract][Full Text] [Related]
13. Cabergoline: long-acting oral treatment of hyperprolactinemic disorders.
Ferrari C; Mattei A; Melis GB; Paracchi A; Muratori M; Faglia G; Sghedoni D; Crosignani PG
J Clin Endocrinol Metab; 1989 Jun; 68(6):1201-6. PubMed ID: 2656736
[TBL] [Abstract][Full Text] [Related]
14. Recovery pattern of hypothalamo-pituitary-testicular axis in patients with macroprolactinomas after treatment with cabergoline.
Walia R; Bhansali A; Dutta P; Khandelwal N; Sialy R; Bhadada S
Indian J Med Res; 2011 Sep; 134(3):314-9. PubMed ID: 21985814
[TBL] [Abstract][Full Text] [Related]
15. Nephrotic-range proteinuria in a patient with a giant prolactinoma.
Heras M; Iglesias P; Fernández-Reyes MJ; Sánchez R; Jiménez MJ; Muñoz H; Tajada P; Duarte J
Am J Kidney Dis; 2008 Jun; 51(6):1025-8. PubMed ID: 18455849
[TBL] [Abstract][Full Text] [Related]
16. Long-term treatment with cabergoline, a new long-lasting ergoline derivate, in idiopathic or tumorous hyperprolactinaemia and outcome of drug-induced pregnancy.
Ciccarelli E; Grottoli S; Razzore P; Gaia D; Bertagna A; Cirillo S; Cammarota T; Camanni M; Camanni F
J Endocrinol Invest; 1997 Oct; 20(9):547-51. PubMed ID: 9413809
[TBL] [Abstract][Full Text] [Related]
17. Pituitary responsiveness to LHRH and TRH in adolescent girls.
Lemarchand-Béraud T; Zufferey M; Reymond M; Rey-Stocker I
Bull Schweiz Akad Med Wiss; 1978 Mar; 34(1-3):241-54. PubMed ID: 96896
[TBL] [Abstract][Full Text] [Related]
18. Osteopenia in children and adolescents with hyperprolactinemia.
Galli-Tsinopoulou A; Nousia-Arvanitakis S; Mitsiakos G; Karamouzis M; Dimitriadis A
J Pediatr Endocrinol Metab; 2000 Apr; 13(4):439-41. PubMed ID: 10777000
[TBL] [Abstract][Full Text] [Related]
19. Outcome of 100 pregnancies initiated under treatment with cabergoline in hyperprolactinaemic women.
Lebbe M; Hubinont C; Bernard P; Maiter D
Clin Endocrinol (Oxf); 2010 Aug; 73(2):236-42. PubMed ID: 20455894
[TBL] [Abstract][Full Text] [Related]
20. Pituitary and testicular response to luteinizing hormone releasing hormone in normal and sulpiride-induced hyperprolactinaemic men.
Nakano R; Yagi S; Nishi T
Exp Clin Endocrinol; 1988 May; 91(2):191-6. PubMed ID: 3137082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
